285 related articles for article (PubMed ID: 25756749)
1. The menagerie of human lipocalins: a natural protein scaffold for molecular recognition of physiological compounds.
Schiefner A; Skerra A
Acc Chem Res; 2015 Apr; 48(4):976-85. PubMed ID: 25756749
[TBL] [Abstract][Full Text] [Related]
2. Anticalins small engineered binding proteins based on the lipocalin scaffold.
Gebauer M; Skerra A
Methods Enzymol; 2012; 503():157-88. PubMed ID: 22230569
[TBL] [Abstract][Full Text] [Related]
3. Anticalins: exploiting a non-Ig scaffold with hypervariable loops for the engineering of binding proteins.
Richter A; Eggenstein E; Skerra A
FEBS Lett; 2014 Jan; 588(2):213-8. PubMed ID: 24239535
[TBL] [Abstract][Full Text] [Related]
4. Alternative binding proteins: anticalins - harnessing the structural plasticity of the lipocalin ligand pocket to engineer novel binding activities.
Skerra A
FEBS J; 2008 Jun; 275(11):2677-83. PubMed ID: 18435758
[TBL] [Abstract][Full Text] [Related]
5. Structural plasticity in the loop region of engineered lipocalins with novel ligand specificities, so-called Anticalins.
Achatz S; Jarasch A; Skerra A
J Struct Biol X; 2022; 6():100054. PubMed ID: 34988429
[TBL] [Abstract][Full Text] [Related]
6. NMR solution structure of lipocalin-type prostaglandin D synthase: evidence for partial overlapping of catalytic pocket and retinoic acid-binding pocket within the central cavity.
Shimamoto S; Yoshida T; Inui T; Gohda K; Kobayashi Y; Fujimori K; Tsurumura T; Aritake K; Urade Y; Ohkubo T
J Biol Chem; 2007 Oct; 282(43):31373-9. PubMed ID: 17715133
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the human odorant binding protein, OBPIIa.
Schiefner A; Freier R; Eichinger A; Skerra A
Proteins; 2015 Jun; 83(6):1180-4. PubMed ID: 25810031
[TBL] [Abstract][Full Text] [Related]
8. Crystallographic analysis of an "anticalin" with tailored specificity for fluorescein reveals high structural plasticity of the lipocalin loop region.
Korndörfer IP; Beste G; Skerra A
Proteins; 2003 Oct; 53(1):121-9. PubMed ID: 12945055
[TBL] [Abstract][Full Text] [Related]
9. Lipocalins as a scaffold.
Skerra A
Biochim Biophys Acta; 2000 Oct; 1482(1-2):337-50. PubMed ID: 11058774
[TBL] [Abstract][Full Text] [Related]
10. The 1.8-A crystal structure of alpha1-acid glycoprotein (Orosomucoid) solved by UV RIP reveals the broad drug-binding activity of this human plasma lipocalin.
Schönfeld DL; Ravelli RB; Mueller U; Skerra A
J Mol Biol; 2008 Dec; 384(2):393-405. PubMed ID: 18823996
[TBL] [Abstract][Full Text] [Related]
11. Multiple molecular recognition properties of the lipocalin protein family.
Flower DR
J Mol Recognit; 1995; 8(3):185-95. PubMed ID: 8573354
[TBL] [Abstract][Full Text] [Related]
12. High-affinity recognition of lanthanide(III) chelate complexes by a reprogrammed human lipocalin 2.
Kim HJ; Eichinger A; Skerra A
J Am Chem Soc; 2009 Mar; 131(10):3565-76. PubMed ID: 19227970
[TBL] [Abstract][Full Text] [Related]
13. The lipocalin protein family: structure and function.
Flower DR
Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):1-14. PubMed ID: 8761444
[TBL] [Abstract][Full Text] [Related]
14. Anticalin® proteins: from bench to bedside.
Deuschle FC; Ilyukhina E; Skerra A
Expert Opin Biol Ther; 2021 Apr; 21(4):509-518. PubMed ID: 33074019
[TBL] [Abstract][Full Text] [Related]
15. NMR structure and dynamics of the engineered fluorescein-binding lipocalin FluA reveal rigidification of beta-barrel and variable loops upon enthalpy-driven ligand binding.
Mills JL; Liu G; Skerra A; Szyperski T
Biochemistry; 2009 Aug; 48(31):7411-9. PubMed ID: 19603796
[TBL] [Abstract][Full Text] [Related]
16. 'Anticalins': a new class of engineered ligand-binding proteins with antibody-like properties.
Skerra A
J Biotechnol; 2001 Jun; 74(4):257-75. PubMed ID: 11526907
[TBL] [Abstract][Full Text] [Related]
17. Distantly related lipocalins share two conserved clusters of hydrophobic residues: use in homology modeling.
Adam B; Charloteaux B; Beaufays J; Vanhamme L; Godfroid E; Brasseur R; Lins L
BMC Struct Biol; 2008 Jan; 8():1. PubMed ID: 18190694
[TBL] [Abstract][Full Text] [Related]
18. Combinatorial design of an Anticalin directed against the extra-domain b for the specific targeting of oncofetal fibronectin.
Gebauer M; Schiefner A; Matschiner G; Skerra A
J Mol Biol; 2013 Feb; 425(4):780-802. PubMed ID: 23238252
[TBL] [Abstract][Full Text] [Related]
19. Structure-guided engineering of Anticalins with improved binding behavior and biochemical characteristics for application in radio-immuno imaging and/or therapy.
Eggenstein E; Eichinger A; Kim HJ; Skerra A
J Struct Biol; 2014 Feb; 185(2):203-14. PubMed ID: 23542582
[TBL] [Abstract][Full Text] [Related]
20. The solution structure and dynamics of human neutrophil gelatinase-associated lipocalin.
Coles M; Diercks T; Muehlenweg B; Bartsch S; Zölzer V; Tschesche H; Kessler H
J Mol Biol; 1999 May; 289(1):139-57. PubMed ID: 10339412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
